ArticleJournal of medical imaging (Bellingham, Wash.)2025
Fine-grained multiclass nuclei segmentation with molecular empowered all-in-SAM model.
Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Purpose: Recent developments in computational pathology have been driven by advances in vision foundation models (VFMs), particularly the Segment Anything Model (SAM). This model facilitates nuclei segmentation through two primary methods: prompt-based zero-shot segmentation and the use of cell-specific SAM models for direct segmentation. These approaches enable effective segmentation across a range of nuclei and cells. However, general VFMs often face challenges with fine-grained semantic segmentation, such as identifying specific nuclei subtypes or particular cells. Approach: In this paper, we propose the molecular empowered all-in-SAM model to advance computational pathology by leveraging the capabilities of VFMs. This model incorporates a full-stack approach, focusing on (1) annotation-engaging lay annotators through molecular empowered learning to reduce the need for detailed pixel-level annotations, (2) learning-adapting the SAM model to emphasize specific semantics, which utilizes its strong generalizability with SAM adapter, and (3) refinement-enhancing segmentation accuracy by integrating molecular oriented corrective learning. Results: Experimental results from both in-house and public datasets show that the all-in-SAM model significantly improves cell classification performance, even when faced with varying annotation quality. Conclusions: Our approach not only reduces the workload for annotators but also extends the accessibility of precise biomedical image analysis to resource-limited settings, thereby advancing medical diagnostics and automating pathology image analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.